E. Seree et al., MODULATION OF MDR1 AND CYP3A EXPRESSION BY DEXAMETHASONE - EVIDENCE FOR AN INVERSE REGULATION IN ADRENALS, Biochemical and biophysical research communications (Print), 252(2), 1998, pp. 392-395
A strong overlap exists between gp170 and CYP3A substrates and inducer
s. In order to investigate a putative coregulation of MDR and CYPA gen
e expression, we measured their transcripts in human liver and after d
examethasone treatment in HepG2 cells or in different mouse tissues. I
n human liver, we observed no correlation between MDR1 and CYP3A4 expr
ession, whereas these genes mere coinduced by dexamethasone in HepG2 c
ells. In mouse liver treated with dexamethasone, mdr1b and Cyp3a were
induced (5- and a-fold, respectively). In adrenals, the main expressin
g gp170 tissue, Cyp3a, was increased while mdr1b was repressed (-51%).
The expression of mdr1b increased in heart, brain, and colon and decr
eased in lung and kidney but Cyp3a was not detectable. In conclusion,
human hepatic CYP3A4 and MDR1 are not corregulated but are coinducible
. lit vivo murine mdr1b and Cyp3a are coregulated by dexamethasone in
liver and inversely regulated in adrenals. (C) 1998 Academic Press.